Another Targeted Therapy for Patients With Multiple Myeloma

A monoclonal antibody that targets the CD38 receptor on multiple myeloma cells has been approved for adults who ’ve received at least 2 prior treatments for the incurable blood cancer.
Source: JAMA - Category: General Medicine Source Type: research